Zobrazeno 1 - 3
of 3
pro vyhledávání: '"José María Serra López-Matencio"'
Autor:
Jacobo Rogado, Nuria Romero-Laorden, José Miguel Sanchez-Torres, Ana María Ramos-Levi, Vilma Pacheco-Barcia, Ana Isabel Ballesteros, Reyes Arranz, Alicia Lorenzo, Pedro Gullon, Ana Garrido, José María Serra López-Matencio, Olga Donnay, Magdalena Adrados, Pablo Costas, Javier Aspa, Arantzazu Alfranca, Rebeca Mondejar, Ramon Colomer
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
Immunotherapy is an effective treatment in advanced cancer, although predictors of response are limited. We studied whether excess weight influences the efficacy outcomes of immunotherapy. We have also evaluated the combined prognostic effect of exce
Externí odkaz:
https://doaj.org/article/c17e72bb7ac94c3c8391d210e75236de
Autor:
José María, Serra López-Matencio, Ana Beatriz, Gago-Veiga, Manuel, Gómez, Estefanía, Alañón Plaza, Gina Paola, Mejía, Miguel Ángel, González-Gay, Santos, Castañeda
Publikováno v:
Expert Opinion on Biological Therapy. 22:707-716
In the few last years, a new family of drugs, anti-calcitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs), has been developed for migraine therapy. Anti-CGRP mAbs are highly effective, but the current limited experience with their use an
Autor:
Pablo Costas, Magdalena Adrados, O. Donnay, Reyes Arranz, Arantzazu Alfranca, Pedro Gullón, V. Pacheco-Barcia, Ana M. Ramos-Leví, A. Ballesteros, Javier Aspa, Ana Garrido, Ramon Colomer, J.M. Sánchez-Torres, José María Serra López-Matencio, R. Mondejar, Nuria Romero-Laorden, A. Lorenzo, Jacobo Rogado
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
Oncoimmunology
Biblos-e Archivo: Repositorio Institucional de la UAM
Universidad Autónoma de Madrid
Biblos-e Archivo. Repositorio Institucional de la UAM
Consejo Superior de Investigaciones Científicas (CSIC)
Oncoimmunology
Biblos-e Archivo: Repositorio Institucional de la UAM
Universidad Autónoma de Madrid
Biblos-e Archivo. Repositorio Institucional de la UAM
Consejo Superior de Investigaciones Científicas (CSIC)
Immunotherapy is an effective treatment in advanced cancer, although predictors of response are limited. We studied whether excess weight influences the efficacy outcomes of immunotherapy. We have also evaluated the combined prognostic effect of exce